Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00722748 · ClinicalTrials.gov registry record
Genomic Investigation of Cardiovascular Diseases
A clinical trial of Coronary Artery Disease and Atrial Fibrillation, sponsored by Scripps Translational Science Institute.
- Active
- Registry status
- 15,000
- Enrollment target
- 1
- Study location
NCT00722748 is a study of Coronary Artery Disease and Atrial Fibrillation that is active but no longer recruiting, run by Scripps Translational Science Institute. The registered enrollment target is 15,000 participants, above the 1,218-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1132% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00722748, a study of Coronary Artery Disease and Atrial Fibrillation, is active but no longer recruiting, sponsored by Scripps Translational Science Institute.
- ACTIVE NOT RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research at Scripps as we strive to stay at the forefront of cardiovascular research in the new century. Human subject donation allows for the creation of the proposed genebank.
Conditions Studied
Study Locations (1)
California
- Scripps Health - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2007-06 |
| Est. Completion | 2030-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00722748
The ClinicalTrials.gov registry entry for NCT00722748 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 15,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,218-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (1132% higher). The listed sponsor is Scripps Translational Science Institute, which has 41 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00722748 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00722748 about?
NCT00722748 is a clinical study titled "Genomic Investigation of Cardiovascular Diseases". This proposal puts forward a research plan to initiate a genetic databank, henceforth referred to as The Genebank at Scripps Clinic Registry. This database will usher in genomic research at Scripps as we strive to stay at the forefront of cardiovascular research in the new century. Human subject don...
What is the current status of trial NCT00722748?
This trial is currently active not recruiting. The enrollment target is 15,000 participants. The study started on 2007-06. Estimated completion is 2030-09.
What conditions does trial NCT00722748 study?
This clinical trial studies the following conditions: Coronary Artery Disease, Atrial Fibrillation, Myocardial Infarction, Aortic Stenosis, Mitral Regurgitation.
Who is sponsoring clinical trial NCT00722748?
This trial is sponsored by Scripps Translational Science Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00722748 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.